Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.2 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 0.2 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |